About Seroquel

In 2004, four medical societies named Seroquel® as one of six anti-psychotic drugs that promote diabetes, obesity or high cholesterol. In February's issue of the journal, Diabetes Care , the American Diabetes Association, the American Psychiatric Association, the North American Association for the Study of Obesity, and the American Association of Clinical Endocrinologists warned that Seroquel users should be watched carefully to ensure that they are not developing diabetes. Additionally, doctors prescribing Seroquel should screen patients carefully for a history of obesity and diabetes in the patient and family, as well as the patient's weight, blood pressure, and cholesterol levels.

Seroquel® manufacturers AstraZeneca have been requested by US regulators to include warnings about the risk of elevated blood sugar and diabetes. The Japanese Seroquel® label includes a prominent warning, specifically stating that there is a link between diabetes and the use of Seroquel. The United States label, however, does not reflect this known problem, meaning that Seroquel users and their physicians may be unaware of the need to monitor for signs of diabetes.

FDA Seroquel Public Health Advisory

Seroquel® Side Effects

If you or someone you know suffered injury after taking Seroquel, call or
e-mail our experienced Texas Seroquel attorneys at 1-800-683-8383 and find out your legal rights.